These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

311 related items for PubMed ID: 1371073

  • 1. Segment spanning residues 727-768 of the complement C3 sequence contains a neoantigenic site and accommodates the binding of CR1, factor H, and factor B.
    Becherer JD, Alsenz J, Esparza I, Hack CE, Lambris JD.
    Biochemistry; 1992 Feb 18; 31(6):1787-94. PubMed ID: 1371073
    [Abstract] [Full Text] [Related]

  • 2. Differences between the binding sites of the complement regulatory proteins DAF, CR1, and factor H on C3 convertases.
    Pangburn MK.
    J Immunol; 1986 Mar 15; 136(6):2216-21. PubMed ID: 2419425
    [Abstract] [Full Text] [Related]

  • 3. Generation of three different fragments of bound C3 with purified factor I or serum. II. Location of binding sites in the C3 fragments for factors B and H, complement receptors, and bovine conglutinin.
    Ross GD, Newman SL, Lambris JD, Devery-Pocius JE, Cain JA, Lachmann PJ.
    J Exp Med; 1983 Aug 01; 158(2):334-52. PubMed ID: 6224880
    [Abstract] [Full Text] [Related]

  • 4. Interaction of vaccinia virus complement control protein with human complement proteins: factor I-mediated degradation of C3b to iC3b1 inactivates the alternative complement pathway.
    Sahu A, Isaacs SN, Soulika AM, Lambris JD.
    J Immunol; 1998 Jun 01; 160(11):5596-604. PubMed ID: 9605165
    [Abstract] [Full Text] [Related]

  • 5. A discontinuous factor H binding site in the third component of complement as delineated by synthetic peptides.
    Lambris JD, Avila D, Becherer JD, Müller-Eberhard HJ.
    J Biol Chem; 1988 Aug 25; 263(24):12147-50. PubMed ID: 2969896
    [Abstract] [Full Text] [Related]

  • 6. Physiologic inactivation of fluid phase C3b: isolation and structural analysis of C3c, C3d,g (alpha 2D), and C3g.
    Davis AE, Harrison RA, Lachmann PJ.
    J Immunol; 1984 Apr 25; 132(4):1960-6. PubMed ID: 6607952
    [Abstract] [Full Text] [Related]

  • 7. Identification of the C3b receptor-binding domain in third component of complement.
    Becherer JD, Lambris JD.
    J Biol Chem; 1988 Oct 05; 263(28):14586-91. PubMed ID: 2971659
    [Abstract] [Full Text] [Related]

  • 8. Common binding region of complement factors B, H and CR1 on C3b revealed by monoclonal anti-C3d.
    Koistinen V, Wessberg S, Leikola J.
    Complement Inflamm; 1989 Oct 05; 6(4):270-80. PubMed ID: 2527715
    [Abstract] [Full Text] [Related]

  • 9. Dissection of CR1, factor H, membrane cofactor protein, and factor B binding and functional sites in the third complement component.
    Lambris JD, Lao Z, Oglesby TJ, Atkinson JP, Hack CE, Becherer JD.
    J Immunol; 1996 Jun 15; 156(12):4821-32. PubMed ID: 8648130
    [Abstract] [Full Text] [Related]

  • 10. Competition for binding sites on C3b by CR1, CR2, MCP, factor B and factor H.
    Farries TC, Seya T, Harrison RA, Atkinson JP.
    Complement Inflamm; 1990 Jun 15; 7(1):30-41. PubMed ID: 2138950
    [Abstract] [Full Text] [Related]

  • 11. Purification and functional analysis of the polymorphic variants of the C3b/C4b receptor (CR1) and comparison with H, C4b-binding protein (C4bp), and decay accelerating factor (DAF).
    Seya T, Holers VM, Atkinson JP.
    J Immunol; 1985 Oct 15; 135(4):2661-7. PubMed ID: 3161944
    [Abstract] [Full Text] [Related]

  • 12. Herpes simplex virus glycoprotein C: molecular mimicry of complement regulatory proteins by a viral protein.
    Huemer HP, Wang Y, Garred P, Koistinen V, Oppermann S.
    Immunology; 1993 Aug 15; 79(4):639-47. PubMed ID: 8406590
    [Abstract] [Full Text] [Related]

  • 13. Protection of the classical and alternative complement pathway C3 convertases, stabilized by nephritic factors, from decay by the human C3b receptor.
    Fischer E, Kazatchkine MD, Mecarelli-Halbwachs L.
    Eur J Immunol; 1984 Dec 15; 14(12):1111-4. PubMed ID: 6240408
    [Abstract] [Full Text] [Related]

  • 14. Unique role of the complement receptor CR1 in the degradation of C3b associated with immune complexes.
    Medof ME, Iida K, Mold C, Nussenzweig V.
    J Exp Med; 1982 Dec 01; 156(6):1739-54. PubMed ID: 7175439
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of human complement by a C3-binding peptide isolated from a phage-displayed random peptide library.
    Sahu A, Kay BK, Lambris JD.
    J Immunol; 1996 Jul 15; 157(2):884-91. PubMed ID: 8752942
    [Abstract] [Full Text] [Related]

  • 16. Residual hemolytic and proteolytic activity expressed by Bb after decay-dissociation of C3b,Bb.
    Fishelson Z, Müller-Eberhard HJ.
    J Immunol; 1984 Mar 15; 132(3):1425-9. PubMed ID: 6229580
    [Abstract] [Full Text] [Related]

  • 17. Probing functional sites on complement protein B with monoclonal antibodies. Evidence for C3b-binding sites on Ba.
    Ueda A, Kearney JF, Roux KH, Volanakis JE.
    J Immunol; 1987 Feb 15; 138(4):1143-9. PubMed ID: 2433342
    [Abstract] [Full Text] [Related]

  • 18. Mapping of the C3d receptor (CR2)-binding site and a neoantigenic site in the C3d domain of the third component of complement.
    Lambris JD, Ganu VS, Hirani S, Müller-Eberhard HJ.
    Proc Natl Acad Sci U S A; 1985 Jun 15; 82(12):4235-9. PubMed ID: 2408276
    [Abstract] [Full Text] [Related]

  • 19. Characterization of three monoclonal antibodies against C3 with selective specificities.
    Iida K, Mitomo K, Fujita T, Tamura N.
    Immunology; 1987 Nov 15; 62(3):413-7. PubMed ID: 2444528
    [Abstract] [Full Text] [Related]

  • 20. Complement C3 convertase: cell surface restriction of beta1H control and generation of restriction on neuraminidase-treated cells.
    Pangburn MK, Müller-Eberhard HJ.
    Proc Natl Acad Sci U S A; 1978 May 15; 75(5):2416-20. PubMed ID: 276881
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.